Dr. Gery Tomassoni
Claim this profileBaptist Health Lexington
Studies Heart Failure
Studies Atrial Fibrillation
11 reported clinical trials
13 drugs studied
Affiliated Hospitals
Clinical Trials Gery Tomassoni is currently running
CCM Device
for Heart Failure
The goal of this clinical trial is to demonstrate that the OPTIMIZER® Integra CCM-D System (the "CCM-D System") can safely and effective convert induced ventricular fibrillation (VF) and spontaneous ventricular tachycardia and/or ventricular fibrillation (VT/VF) episodes in subjects with Stage C or D heart failure who remain symptomatic despite being on guideline-directed medical therapy (GDMT), are not indicated for cardiac resynchronization therapy (CRT), and have heart failure with reduced left ventricular ejection fraction (LVEF ≤40%). Eligible subjects will be implanted with the CCM-D System. A subset of subjects will be induced into ventricular fibrillation "on the table" in the implant procedure room. During the follow-up period, inappropriate shock rate and device-related complications will be evaluated. The follow-up period is expected to last at least two years.
Recruiting1 award N/A8 criteria
Left Atrial Appendage Occlusion vs. NOAC
for Atrial Fibrillation
The objective of this trial is to evaluate the safety and effectiveness of the Amulet LAA occluder compared to NOAC therapy in patients with non-valvular AF at increased risk for ischemic stroke and who are recommended for long-term NOAC therapy. The clinical investigation is a prospective, randomized, multicenter active control worldwide trial. Subjects will be randomized in a 1:1 ratio between the Amulet LAA occlusion device ("Device Group") and a commercially available NOAC medication ("Control Group"). The choice of NOAC in the Control Group will be left to study physician discretion.
Recruiting1 award N/A8 criteria
More about Gery Tomassoni
Clinical Trial Related2 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Gery Tomassoni has experience with
- Dronedarone
- Aveir DR Leadless Pacemaker System
- FARAPULSE Ablation System
- OPTIMIZER Smart
- Amplatzer Amulet LAA Occluder
- Non-Vitamin K Oral Antagonists
Breakdown of trials Gery Tomassoni has run
Heart Failure
Atrial Fibrillation
Cardiac Arrhythmias
Arrhythmia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Gery Tomassoni specialize in?
Gery Tomassoni focuses on Heart Failure and Atrial Fibrillation. In particular, much of their work with Heart Failure has involved treating patients, or patients who are undergoing treatment.
Is Gery Tomassoni currently recruiting for clinical trials?
Yes, Gery Tomassoni is currently recruiting for 2 clinical trials in Lexington Kentucky. If you're interested in participating, you should apply.
Are there any treatments that Gery Tomassoni has studied deeply?
Yes, Gery Tomassoni has studied treatments such as Dronedarone, Aveir DR Leadless Pacemaker System, FARAPULSE Ablation System.
What is the best way to schedule an appointment with Gery Tomassoni?
Apply for one of the trials that Gery Tomassoni is conducting.
What is the office address of Gery Tomassoni?
The office of Gery Tomassoni is located at: Baptist Health Lexington, Lexington, Kentucky 40223 United States. This is the address for their practice at the Baptist Health Lexington.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.